Amyloid fibril formation by a normally folded protein in the absence of denaturants and agitation

References

• Stefani M, Dobson CM. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 2003;81:678–99
   PubMed Web of Science ®Google Scholar
• Uversky VN, Fink AL. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta 2004;1698:131–53
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. Folding proteins in fatal ways. Nature. 2003;426:900–4
   PubMed Web of Science ®Google Scholar
• Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Ann Rev Biochem 2006;75:333–66
   PubMed Web of Science ®Google Scholar
• Fowler DM, Koulov AV, Balch WE, Kelly JW. Functional amyloid – from bacteria to humans. Trends Biochem Sci 2007;32:217–24
   PubMed Web of Science ®Google Scholar
• Iconomidou VA, Hamodrakas SJ. Natural protective amyloids. Curr Protein Pept Sci 2008;9:291–309
   PubMed Web of Science ®Google Scholar
• Shewmaker F, McGlinchey RP, Wickner RB. Structural insights into functional and pathological amyloid. J Biol Chem 2011;286:16533–40
   PubMed Web of Science ®Google Scholar
• Hamley IW. Peptide fibrillization. Angew Chem Int Ed Engl 2007;46:8128–47
   PubMed Web of Science ®Google Scholar
• Cherny I, Gazit E. Amyloids: not only pathological agents but also ordered nanomaterials. Angew Chem Int Ed Engl 2008;47:4062–9
   PubMed Web of Science ®Google Scholar
• Guijarro JI, Sunde M, Jones JA, Campbell ID, Dobson CM. Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci USA 1998;95:4224–8
   PubMed Web of Science ®Google Scholar
• McParland VJ, Kad NM, Kalverda AP, Brown A, Kirwin-Jones P, Hunter MG, Sunde M, et al. Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro. Biochemistry 2000;39:8735–46
   PubMed Web of Science ®Google Scholar
• Marcon G, Plakoutsi G, Canale C, Relini A, Taddei N, Dobson CM, Ramponi G, et al. Amyloid formation from HypF-N under conditions in which the protein is initially in its native state. J Mol Biol 2005;347:323–35
   PubMed Web of Science ®Google Scholar
• Schmittschmitt JP, Scholtz JM. The role of protein stability, solubility, and net charge in amyloid fibril formation. Protein Sci 2003;12:2374–8
   PubMed Web of Science ®Google Scholar
• Litvinovich SV, Brew SA, Aota S, Akiyama SK, Haudenschild C, Ingham KC. Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. J Mol Biol 1998;280:245–58
   PubMed Web of Science ®Google Scholar
• Fändrich M, Fletcher MA, Dobson CM. Amyloid fibrils from muscle myoglobin. Nature 2001;410:165–6
   PubMed Web of Science ®Google Scholar
• Ferrão-Gonzales AD, Souto SO, Silva JL, Foguel D. The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state. Proc Natl Acad Sci USA 2000;97:6445–50
   PubMed Web of Science ®Google Scholar
• De Felice FG, Vieira MN, Meirelles MN, Morozova-Roche LA, Dobson CM, Ferreira ST. Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure. FASEB J 2004;18:1099–101
   Google Scholar
• Sasahara K, Yagi H, Sakai M, Naiki H, Goto Y. Amyloid nucleation triggered by agitation of beta2-microglobulin under acidic and neutral pH conditions. Biochemistry 2008;47:2650–60
   PubMed Web of Science ®Google Scholar
• Sicorello A, Torrassa S, Soldi G, Gianni S, Travaglini-Allocatelli C, Taddei N, Relini A, et al. Agitation and high ionic strength induce amyloidogenesis of a folded PDZ domain in native conditions. Biophys J 2009;96:2289–98
   PubMed Web of Science ®Google Scholar
• Jaeger KE, Reetz MT. Microbial lipases from versatile tools for biotechnology. Trends Biotechnol 1998;16:396–403
   PubMed Web of Science ®Google Scholar
• Reetz MT. Lipases as practical biocatalysts. Curr Opin Chem Biol 2002;6:145–50
   PubMed Web of Science ®Google Scholar
• Akbari N, Khajeh K, Rezaie S, Mirdamadi S, Shavandi M, Ghaemi N. High level expression of lipase in Escherichia coli and recovery of active recombinant enzyme through in vitro refolding. Protein Exp Purif 2010;70:75–80
   PubMed Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–5
   PubMed Web of Science ®Google Scholar
• Johnson WC Jr. Protein secondary structure and circular dichroism: a practical guide. Proteins 1990;7:205–14
   PubMed Web of Science ®Google Scholar
• Oberg K, Chrunyk BA, Wetzel R, Fink AL. Native-like secondary structure in interleukin-1β inclusion bodies by attenuated total reflectance FTIR. Biochemistry 1994;33:2628–34
   PubMed Web of Science ®Google Scholar
• Venyaminov SYu, Vassilenko KS. Determination of protein tertiary structure class from circular dichroism spectra. Anal Biochem 1994;222:176–84
   PubMed Web of Science ®Google Scholar
• Soldi G, Bemporad F, Torrassa S, Relini A, Ramazzotti M, Taddei N, Chiti F. Amyloid formation of a protein in the absence of initial unfolding and destabilization of the native state. Biophys J 2005;89:4234–44
   PubMed Web of Science ®Google Scholar
• Castiglioni E, Abbate S, Longhi G, Gangemi R. Wavelength shifts in solid-state circular dichroism spectra: a possible explanation. Chirality 2007;19:491–6
   PubMed Web of Science ®Google Scholar
• Akbari N, Khajeh K, Ghaemi N, Salemi N. Efficient refolding of recombinant lipase from Escherichia coli inclusion bodies by response surface methodology. Protein Expr Purif 2010;70:254–9
   PubMed Web of Science ®Google Scholar
• Akbari N, Daneshjoo S, Akbari J, Kajeh K. Isolation, characterization and catalytic properties of a novel lipase which is activated in ionic liquids and organic solvents. Appl Biochem Biotechnol 2011;165:785–94
   PubMed Web of Science ®Google Scholar
• Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, Dobson CM. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA 1999;96:3590–4
   PubMed Web of Science ®Google Scholar
• Dobson CM. Protein folding and misfolding. Nature 2003;426:884–90
   PubMed Web of Science ®Google Scholar
• Jarrett JT, Berger EP, Lansbury PT Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation implications for the pathogenesis of Alzheimer’s disease. Biochemistry 1993;32:4693–7
   PubMed Web of Science ®Google Scholar
• Starck CS, Sutherland-Smith AJ. Cytotoxic aggregation and amyloid formation by the myostatin precursor protein. PLoS One 2010;5:e9170
   Web of Science ®Google Scholar
• Ye Z, Bayron Poueymiroy D, Aguilera JJ, Srinivasan S, Wang Y, Serpell LC, Colón W. Inflammation protein SAA2.2 spontaneously forms marginally stable amyloid fibrils at physiological temperature. Biochemistry 2011;5:9184–91
   Google Scholar